Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer

NCT04954378 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04954378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
December 30, 2020
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma